When was DNA Script founded?

DNA Script was founded in 2014 and raised its 1st funding round 3 years after it was founded.

Where is DNA Script located?

DNA Script is headquartered in Paris, France.

How many employees does DNA Script have?

As of Mar 31, 2026, the latest employee count at DNA Script is 141.

Is DNA Script a funded company?

DNA Script is a funded company, having raised a total of $315M across 10 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Sep 12, 2017.

When was the latest funding round of DNA Script?

DNA Script's latest funding was a $***** Grant (prize money) round on Sep 01, 2023, with participation from 1 investor.

What is the annual revenue of DNA Script?

Annual revenue of DNA Script is €5.17M as on Dec 31, 2022.

Where does DNA Script rank among its competitors?

DNA Script ranks 5th amongst 47 active competitors, of which 14 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Ansa Biotechnologies, which secured $54.4M in Oct, 2025.

Who are the top competitors of DNA Script?

DNA Script's top competitors include Ansa Biotechnologies, Twist Bioscience and Nutcracker Therapeutics. Among them, Ansa Biotechnologies secured the most recent funding round in October, 2025.

DNA Script - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

DNA script is a developer of a benchtop DNA printer powered by enzymatic technology for nucleic acid syntheis. It is offering a benchtop DNA printer that provides outsourced chemical-based DNA synthesis through enzymatic synthesis technology to synthesize DNA.

Website: www.dnascript.com/
Social
Email ID: *****@dnascript.co
Phone Number: +33 **********

Key Metrics

Founded Year

2014

Location

Paris, France

Stage

Series C

Total Funding

$315M in 10 rounds

Latest Funding Round

Grant (prize money), Sep 01, 2023, $*****

Investors

T. Rowe Price & 28 more

Ranked

5^th among 47 active competitors

Annual Revenue

€5.17M as on Dec 31, 2022

Employee Count

141 as on Mar 31, 2026

Similar Companies

Ansa Biotechnologies & 55 more

View DNA Script's full profile

DNA Script is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Dna Script CIN: 801172834 , France, Active	Mar 20, 2014	$5.45M (As on Dec 31, 2022)	-	-

DNA Script has raised a total funding of $315M over 10 rounds. Its first funding round was on Sep 12, 2017. Its latest funding round was a Grant (prize money) round on Sep 01, 2023 for $*****. 1 investor participated in its latest round. DNA Script has 29 institutional investors.

Here is the list of recent funding rounds of DNA Script:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 01, 2023	3261830	Grant (prize money)	5572289	7649413	6721997	5281005
Jan 04, 2022	9549419	Series C	1718380	5783361	2378773	9866894
Oct 27, 2021	2519655	Series C	9040854	7750398	Coatue & 1 more	Columbia Threadneedle Investments & 13 more

Access funding benchmarks and valuations. Sign up today!

View details of DNA Script's funding rounds and investors

The founders of DNA Script are Xavier Godron, Sylvain Gariel and Thomas Ybert.

Here are the details of DNA Script's key team members:

Xavier Godron: Co-Founder of DNA Script. They are also an angel investor in 1 startup.
Contact Info: 1 email address
Sylvain Gariel: Co-Founder of DNA Script and founder of 1 other company. They are also an angel investor in 1 startup.
Thomas Ybert: Co-Founder & CEO of DNA Script and founder of 1 other company.

View details of DNA Script's Founder profiles and Board Members

DNA Script's employee count trend

DNA Script has 141 employees as of Mar 26. Here is DNA Script's employee count trend over the years:

Uncover DNA Script's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of DNA Script include Ansa Biotechnologies, Twist Bioscience and Nutcracker Therapeutics. Here is the list of Top 10 competitors of DNA Script, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ansa Biotechnologies 2017, Berkeley (United States), Series B	Provider of DNA synthesis technology using enzymes	$177M	Fifty Years, Northpond Ventures & 15 others	68/100
2nd	Twist Bioscience 2013, San Francisco (United States), Public	Developer of a semiconductor-based DNA synthesis platform	$321M	Foresite Capital, Fidelity Investments & 39 others	63/100
3rd	Nutcracker Therapeutics 2018, Emeryville (United States), Series C	Developer of mRNA therapeutics	$227M	Arch Venture Partners, ND Capital & 3 others	56/100
4th	Sensible Biotechnologies 2021, Wilmington (United States), Seed	Developer of mRNA technology for therapeutics and vaccines	$4.32M	Y Combinator, BlueYard & 6 others	56/100
5th	DNA Script 2014, Paris (France), Series C	Developer of benchtop DNA printer for nucleic acid synthesis	$315M	ArrowMark Partners, EQT & 27 others	56/100
6th	Synbio Tech 2013, Suzhou (China), Seed	Synthetic biology techniques and bioinformatic tools for gene synthesis, cloning and antibody optimization	-	Alwin Capital, Co-win Ventures & 1 others	47/100
7th	Mesa Biotech 2009, San Diego (United States), Acqui-Hired	Provider of point-of-care molecular diagnostic kits	$26.8M	Public Health Emergency, Phase Two Ventures ... & 3 others	45/100
8th	OriCiro Genomics 2018, Tokyo (Japan), Acquired	Developer of technologies for DNA synthesis and amplification	$10.9M	UTEC, Asahi Kasei & 3 others	44/100
9th	Cambrian Genomics 2011, San Francisco (United States), Series A	Genomics company focused on understanding, manipulating, and improving human health	$11.2M	Edelweiss, Western Technology Investment ... & 11 others	42/100
10th	Synple Chem 2016, Zurich (Switzerland), Acquired	Developer of automated chemical synthesizers using reagent capsules	$10.2K	EIC Fund, Venture Kick & 1 others	41/100